Եվրոպական Միություն -
իսլանդերեն -
EMA (European Medicines Agency)
byooviz
samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - augnlækningar - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
Եվրոպական Միություն -
իսլանդերեն -
EMA (European Medicines Agency)
ximluci
stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - augnlækningar - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
Եվրոպական Միություն -
իսլանդերեն -
EMA (European Medicines Agency)
ranivisio
midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - augnlækningar - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
Իսլանդիա -
իսլանդերեն -
LYFJASTOFNUN (Icelandic Medicines Agency)
taptiqom sine (taptiqom) augndropar, lausn 15 microg/ml + 5 mg/ml
santen oy* - tafluprostum inn; timololum maleat - augndropar, lausn - 15 microg/ml + 5 mg/ml
Իսլանդիա -
իսլանդերեն -
LYFJASTOFNUN (Icelandic Medicines Agency)
asacol (mesalazine espl) endaþarmsstíll 1 g
tillotts pharma ab - mesalazinum inn - endaþarmsstíll - 1 g
Իսլանդիա -
իսլանդերեն -
LYFJASTOFNUN (Icelandic Medicines Agency)
zaditen augndropar, lausn í stakskammtaíláti 0,25 mg/ml
laboratoires thea s.a.s. - ketotifenum fúmarat - augndropar, lausn í stakskammtaíláti - 0,25 mg/ml
Իսլանդիա -
իսլանդերեն -
LYFJASTOFNUN (Icelandic Medicines Agency)
fixopost (monoprostduo) augndropar, lausn í stakskammtaíláti 50 míkróg/ml + 5 mg/ml
laboratoires thea* - latanoprostum inn; timololum maleat - augndropar, lausn í stakskammtaíláti - 50 míkróg/ml + 5 mg/ml
Իսլանդիա -
իսլանդերեն -
LYFJASTOFNUN (Icelandic Medicines Agency)
hydrocortison med terramycin og polymyxin b eyrna-/augndropar, dreifa
pfizer aps - polymyxinum b súlfat; oxytetracyclinum hýdróklóríð; hydrocortisonum acetat - eyrna-/augndropar, dreifa
Իսլանդիա -
իսլանդերեն -
LYFJASTOFNUN (Icelandic Medicines Agency)
phosphoral mixtúra, lausn 24,4 g/10,8 g
casen recordati s.l. - dinatrii hydrogenophosphas; natrii dihydrogenophosphas - mixtúra, lausn - 24,4 g/10,8 g
Իսլանդիա -
իսլանդերեն -
LYFJASTOFNUN (Icelandic Medicines Agency)
taflotan augndropar, lausn í stakskammtaíláti 15 míkróg/ml
santen oy* - tafluprostum inn - augndropar, lausn í stakskammtaíláti - 15 míkróg/ml